The criteria include neurofibromas, ≥6 café-au-lait macules (CALMs), optic glioma, Lisch nodules, axillary/inguinal freckling, distinctive bony lesions, or a pathogenic NF1 mutation [3]. Here, NF1 is linked to plexiform neurofibroma.